Back

Association of CCL17 with risk of major adverse cardiovascular events: a prospective cohort study

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers (3) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Zeyuan Wang

Beijing (China)

3 More presentations in this session

Presentation thumbnail
Machine learning-based identification of a proteomics panel for predicting cardiovascular outcomes in the community
Mr E. Santana (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Immunoglobulin G N-glycosylation as a novel biomarker for premature myocardial infarction: a case-control study
Doctor M. Ammar (Boston, US)
Abstract Slides Video
Presentation thumbnail
Cystatin C predicts mortality in patients with coronary artery disease both among subjects with and among those without the metabolic syndrome
Doctor A. Mader (Feldkirch, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers (3)

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
CCL17 as a biomarker of premature atherosclerosis in the early development of systemic lupus erythematosus: insights from the Chinese CSTAR cohorts
thumbnail
Congress Session
Novel biomarkers for cardiovascular risk assessment
thumbnail
Congress Session
Secondary prevention: biomarkers to optimise outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources